Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
01/2009
01/22/2009US20090022774 Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances for treatment of vascular disorder
01/22/2009CA2699971A1 Spiro condensed barbituric acid derivatives for use as antibacterial
01/22/2009CA2693594A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors
01/21/2009EP2016944A2 Angiogenesis inhibitor containing a derivative of rifampicin
01/21/2009EP2016047A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
01/21/2009EP1549655B1 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use
01/21/2009EP0958291B1 3-heterocyclyl-substituted benzoyl derivatives
01/21/2009CN101351452A Hiv整合酶抑制剂 Hiv integrase inhibitors
01/21/2009CN101351206A Therapeutic agent for liver disease and hepatic function-
01/21/2009CN100454581C 有机薄膜晶体管 The organic thin film transistor
01/20/2009US7479500 Antidepressant piperidine derivatives of heterocyclefused benzodioxans
01/15/2009WO2008112483A3 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
01/15/2009US20090018332 Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors
01/15/2009US20090018331 Condensed imidazole derivatives
01/15/2009US20090018317 Reactive dyestuffs with alkylthio group and beta-sulfatoethysulfone group
01/14/2009EP2013218A2 Raf inhibitors and their uses
01/14/2009EP2013206A1 Pharmaceutical compounds
01/14/2009EP2013182A2 Aminoquinolones as gsk-3 inhibitors
01/14/2009EP2013167A2 Total synthesis of salinosporamide a and analogs thereof
01/14/2009EP2013163A1 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
01/14/2009EP1560584B1 Fab i inhibitors
01/14/2009EP1516620B1 Rifampicin for treating angiogenesis
01/14/2009CN101346387A Pyrimido- [4, 5-]-oxazines for use as DGAT inhibitors
01/14/2009CN101346386A Process for the preparation of S-(+)-clopidogrel by optical resolution
01/14/2009CN101346370A PDF inhibitors
01/13/2009US7476688 Cyclic amidine derivatives
01/08/2009WO2009006243A2 Processes for preparing bicyclic oxazine carboxaldehyde and beta-lactamase inhibitors
01/08/2009WO2009005729A1 Gamma secretase modulators
01/08/2009WO2009004382A2 3-spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents
01/08/2009WO2009003595A2 Macrolactone derivatives
01/08/2009US20090012074 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the Dopamine D3 receptor
01/08/2009US20090012073 N-aroyl cyclic amines
01/08/2009US20090012071 4-substituted-1h-isothiazolo[5,4-b][1,4]oxazino[2,3,4-ij]quinoline-7,8(2h,9h)-diones and related compounds as anti-infective agents
01/08/2009US20090012068 Condensed Imidazole Derivatives as Aldosterone Synthase Inhibitors
01/08/2009CA2692260A1 Macrolactone derivatives
01/08/2009CA2692253A1 Gamma secretase modulators
01/08/2009CA2691485A1 Chemical compounds
01/07/2009EP2010540A1 Spiro-imidazo compounds
01/07/2009EP2010532A1 Tryclic nitrogen containing compounds and their use as antibacterials
01/07/2009EP1562589B1 Diaminotriazoles useful as inhibitors of protein kinases
01/07/2009CN101341150A Nitroimidazole compounds
01/07/2009CN101341123A 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
01/07/2009CN101340907A Diazonamide a analog
01/07/2009CN100448874C N-aroyl cyclic amines
01/06/2009US7473796 Maytansinoid intermediates: N-alkyl- or aryldithioalkanoylalanines and N-alkanoyl- or aroylthioalkanoylalanines, e.g., N-methyl-N-(4-methyl-4-methyldithio-1-oxopentyl)-alanine; optical isomers and racemic mixtures; preparations from isobutylene sulfide and acetonitrile, methyl methanethiosulfonate, etc.
01/06/2009US7473783 Bicyclic pyrazolo protein kinase modulators
01/06/2009US7473691 Pyrazole compounds useful as protein kinase inhibitors
01/06/2009US7473366 Process for the purification of macrolides
01/02/2009DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
01/01/2009US20090005572 Methods for preparing diazonamides
01/01/2009US20090005558 (2-{7-[3-(4-cyanophenoxy)propyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}ethyl) carbamic acid tert-butyl ester; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction
01/01/2009US20090005371 Substituted Fused [1,2]Imidazo[4,5-C] Ring Compounds and Methods
01/01/2009US20090005368 such as 6-({trans-4-[(1R)-1-hydroxy-2-(3-methoxy-quinolin-5-yl)-ethyl]-cyclohexylamino}-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one for treating infections from Streptococcus pneumoniae, Haemophilus influenzae, Moraxella, Staphylococcus, Enterococcus
01/01/2009US20090005334 Nucleic acid derivatives
01/01/2009US20090004508 Thin-film materials, thin films and producing method thereof
12/2008
12/31/2008WO2009001214A2 Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists
12/31/2008WO2009001126A1 Substituted piperidine derivatives and their use as antibaterial agents
12/31/2008EP2008657A2 Use of rapamycin derivatives in vasculopathies
12/31/2008EP2007789A2 Hcv/hiv inhibitors and their uses
12/31/2008EP2007770A1 Imidazo compounds
12/31/2008EP2007748A2 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
12/31/2008EP2007725A2 Non-peptidic renin inhibitors nitroderivatives
12/31/2008EP1648905B1 Thienopyridine and furopyridine kinase inhibitors
12/31/2008CN100447145C 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof
12/31/2008CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors
12/30/2008US7470707 Crystalline monohydrate clopidogrel naphthalenedisulfonate and process of preparation
12/30/2008US7470691 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
12/30/2008US7470690 4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorder
12/30/2008US7470684 Spiropiperidine derivatives as NK3 antagonists
12/30/2008US7470683 Tetracyclic compounds
12/25/2008US20080319198 N-benzyl-N-{2-[7-(4-cyanobenzyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]ethyl}methane-sulfonamide; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction
12/25/2008US20080319032 Tetrahydrobenzothiazole analogues as neuroprotective agents
12/25/2008US20080318940 Quinazolinone Derivatives as Vanilloid Antagonists
12/24/2008WO2008157162A1 Dipeptide analogs as coagulation factor inhibitors
12/24/2008WO2008155728A1 Process for preparing amorphous rifaximin and the amorphous rifaximin thus obtained
12/24/2008EP2004659A1 Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
12/24/2008EP2004658A1 Condensed imidazole derivatives as aromatase inhibitors
12/24/2008EP2004657A1 Condensed imidazole derivatives as aldosterone synthase inhibitors
12/24/2008EP1687314B1 PREPARATION OF 1-AZA-2-OXA-DIBENZO [e,h] AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
12/24/2008EP1147115B3 Tricyclic benzodiazepines as vasopressin receptor antagonists
12/24/2008CN101331138A One pot synthesis of tetrazole derivatives of sirolimus
12/24/2008CA2691394A1 Process for preparing amorphous rifaximin and the amorphous rifaximin thus obtained
12/23/2008US7468377 Imidazopyridine-derivatives as inductible no-synthase inhibitors
12/23/2008US7468376 Pyrazolopyridine derivates
12/23/2008US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression;
12/23/2008CA2560580C Imidazole compounds for inhibition of a.beta.-peptide production and for modulation of the notch signaling pathway
12/23/2008CA2424664C Novel non-imidazole compounds
12/18/2008WO2008153793A2 Gamma secretase modulators
12/18/2008WO2008153792A2 Gamma secretase modulators
12/18/2008WO2008152603A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
12/18/2008US20080312438 -(2-Aminopyrid-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for immunoglobulins IgE and IgG antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis, multiple sclerosis
12/18/2008US20080312267 Diagnosis and Treatment of Diseases Arising from Defects in the Tuberous Sclerosis Pathway
12/18/2008US20080312218 Fused tetracyclic mglur1 antagonists as therapeutic agents
12/18/2008US20080312203 such as (5R,6Z)-6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, in combination with beta-lactam antibiotics, for the treatment of bacterial infections
12/18/2008DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
12/18/2008CA2689948A1 Gamma secretase modulators
12/18/2008CA2689930A1 Gamma secretase modulators
12/18/2008CA2689102A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
12/17/2008EP2001891A1 Buprenorphine derivatives and uses thereof
12/17/2008EP2001879A1 Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 220